share_log

Teva Pharmaceutical Industries(TEVA.US) Director Sells US$6.29 Million in Common Stock

Moomoo News ·  Dec 27 05:09

$Teva Pharmaceutical Industries (TEVA.US)$ Director MIGNONE ROBERTO sold 286K shares of common stock on Dec 20, 2024 at an average price of $22.0071 for a total value of $6.29 million.

1735247369428873472.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment